Sanofi (SNY +4.8%) is higher today after the FDA approves Zaltrap, a drug developed by SNY and...

|About: Sanofi (SNY)|By:, SA News Editor

Sanofi (SNY +4.8%) is higher today after the FDA approves Zaltrap, a drug developed by SNY and Regeneron Pharmaceuticals (REGN +1%) for the treatment of advanced colon cancer.